⌘K

Login Start Free

Home/Filings/4/0001415889-24-024381

4//SEC Filing

Harsch Mutya 4

Accession 0001415889-24-024381

CIK 0001566044other

View on SEC.gov Company Profile

Filed

Oct 1, 8:00 PM ET

Accepted

Oct 2, 4:15 PM ET

Size

5.1 KB

Accession

0001415889-24-024381

Insider Transaction Report

Form 4

Period: 2024-09-30

VYNE Therapeutics Inc.VYNE

CHIEF LEGAL OFFICER AND GC

Transactions

Tax Payment
Common Stock
2024-09-30$1.88/sh−105$197→ 149,026 total

Footnotes (1)

[F1]Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.

Documents

1 file

4
form4-10022024_041004.xmlPrimary

Issuer

VYNE Therapeutics Inc.

CIK 0001566044

Entity typeother

Related Parties

1

filerCIK 0001727809

Filing Metadata

Form type: 4
Filed: Oct 1, 8:00 PM ET
Accepted: Oct 2, 4:15 PM ET
Size: 5.1 KB

View on SEC.gov